Pharmacogenomics deals with the effects of genetic variation on a patient’s drug response by associating gene expression changes and single nucleotide polymorphisms (SNPs) with drug efficacy or toxicity. The growing need for early detection of drug advertising, drug safety, and rapid compliance with regulatory guidelines has led pharmaceutical companies and other intermediaries to adopt new technologies and methods. These developments are expected to spur adoption of drug genomics technology during the forecast period.

Based on technology, the market is divided into microarrays, sequencing, and polymerase chain reaction. Sequencing segments are broken down into ginger, pyrosequencing, and next-generation sequencing. Applications based on the market are classified as oncology, cardiology, neurological disorders and others. Oncology is categorized by technology into breast cancer, lung cancer and other areas. Based on end users, markets are divided into hospitals, research institutes, and academic institutions.

Top Companies Profiled in this Report includes, Abbott Laboratories, Inc., Affymetrix, Inc., AstraZeneca plc, Assurex Health, Bayer AG, GeneDX, F. Hoffmann-La Roche Ltd., Illumina, Inc., Myriad Genetics, Inc., Merck & Co, GE Healthcare, GlaxoSmithKline, Johnson & Johnson, Pfizer, Inc., Pathway Genomics, Qiagen, Inc., Teva Pharmaceutical Industries Ltd, Thermo Fisher Scientific, Transgenomic, Inc.

Pharmacogenomics Key Market Segments:

Pharmacogenomics Market by Technology:

  • Polymerase Chain Reaction
  • Microarray
  • Sequencing
  • Mass Spectrometry
  • Electrophoresis
  • Others

Pharmacogenomics Market by Application:

  • Oncology
  • Infectious diseases
  • Cardiovascular diseases
  • Neurological diseases
  • Psychiatry
  • Pain management
  • Others

Pharmacogenomics Market By End User:

  • Hospitals and clinics
  • Research institutions
  • Academic institutes

Pharmacogenomics Market By Region:

  • North America (U.S. and Canada)
  • Latin America (Mexico, Brazil, Peru, Chile, and others)
  • Western Europe (Germany, U.K., France, Spain, Italy, Nordic countries, Belgium, Netherlands, and Luxembourg)
  • Eastern Europe (Poland and Russia)
  • Asia Pacific (China, India, Japan, ASEAN, Australia, and New Zealand)
  • Middle East and Africa (GCC, Southern Africa, and North Africa)

For More Information: https://www.qyreports.com/report/global-pharmacogenomics-market-research-report-2019-116569/